drugset / Trial / NCT02528201
A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis
RandomizedParallel-groupDouble-blindTreatment
Summary
A clinical trial to assess the effect of celecoxib 200 milligrams (mg) once daily and 400 milligrams (mg) once daily compared to diclofenac three times daily in the treatment of Ankylosing Spondylitis (AS) for 12 weeks. This will be used to confirm the results of a prior 6 week trial.
Timeline
- Start
- 2002-09
- Primary completion
- 2004-11
- Completion
- 2004-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 200 mg | — |
| Comparator | Celecoxib | Other / unclassified | 400 mg | — |
| Comparator | Diclofenac | Other / unclassified | 50 mg | — |